title: D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry.
abstract: BACKGROUND
  A number of variables have been evaluated for risk stratification in patients with acute pulmonary embolism (PE). Whereas increased D-dimer levels have been associated with mortality at 3 months, its role in predicting short-term outcome (the period of time during which any therapeutic decision has to be taken) remains unclear.
  
  
  METHODS
  RIETE is an ongoing, prospective registry of consecutive patients with acute venous thromboembolism. We assessed the prognostic value of D-dimer levels at baseline, measured with an automated latex agglutination test (IL Test D-dimer), on the 15-day outcome in patients with acute PE. Overall mortality, fatal PE and major bleeding rates were compared by quartile.
  
  
  RESULTS
  As of February 2008, 1707 patients with acute PE underwent D-dimer testing. Of these, 72 patients (4.2%) died during the first 15 days, 11 (0.6%) had recurrent PE, and 29 (1.7%) had major bleeding. Overall mortality increased with increasing D-dimer levels, from 2.7% in the first quartile (< 1050 ng mL(-1)) to 7.0% in the fourth quartile (>or= 4200 ng mL(-1)). The rates of fatal PE and major bleeding also increased. On multivariate analysis, patients with D-dimer levels in the fourth quartile had an increased risk for overall death (odds ratio, 1.8; 95% CI, 1.1-3.2), fatal PE (odds ratio, 2.0; 95% CI, 1.0-3.8) or major bleeding (odds ratio, 3.2; 95% CI, 1.5-7.0).
  
  
  CONCLUSIONS
  PE patients with D-dimer levels in the fourth quartile had an increased incidence of overall death, fatal PE and major bleeding within 15 days both before and after multivariate adjustment.
authors.affiliation: Servicio de Neumología, Hospital Txagorritxu, Vitoria, Spain.
authors.forename: J L
authors.initials: JL
authors.lastname: Lobo
authors.forename: V
authors.initials: V
authors.lastname: Zorrilla
authors.forename: F
authors.initials: F
authors.lastname: Aizpuru
authors.forename: E
authors.initials: E
authors.lastname: Grau
authors.forename: D
authors.initials: D
authors.lastname: Jiménez
authors.forename: G
authors.initials: G
authors.lastname: Palareti
authors.forename: M
authors.initials: M
authors.lastname: Monreal
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011655:Pulmonary Embolism / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D012042:Registries; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D